0001922140-24-000001.txt : 20240131
0001922140-24-000001.hdr.sgml : 20240131
20240131183946
ACCESSION NUMBER: 0001922140-24-000001
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240130
FILED AS OF DATE: 20240131
DATE AS OF CHANGE: 20240131
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ma-Weaver Jacob
CENTRAL INDEX KEY: 0001922140
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-22873
FILM NUMBER: 24584399
MAIL ADDRESS:
STREET 1: 2261 MARKET STREET
STREET 2: #4307
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94114
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARCA biopharma, Inc.
CENTRAL INDEX KEY: 0000907654
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 363855489
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10170 CHURCH RANCH WAY
STREET 2: SUITE 100
CITY: WESTMINSTER
STATE: CO
ZIP: 80021
BUSINESS PHONE: 7209402200
MAIL ADDRESS:
STREET 1: 10170 CHURCH RANCH WAY
STREET 2: SUITE 100
CITY: WESTMINSTER
STATE: CO
ZIP: 80021
FORMER COMPANY:
FORMER CONFORMED NAME: NUVELO INC
DATE OF NAME CHANGE: 20030203
FORMER COMPANY:
FORMER CONFORMED NAME: HYSEQ INC
DATE OF NAME CHANGE: 19970610
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0508
4
2024-01-30
0
0000907654
ARCA biopharma, Inc.
ABIO
0001922140
Ma-Weaver Jacob
2261 MARKET STREET
#4307
SAN FRANCISCO
CA
94114
1
0
1
1
See footnote 1
0
Stock option (right to buy)
1.64
2024-01-30
4
A
0
6000
0
A
2034-01-30
Common stock
6000
6000
D
This Form 4 is filed by Jacob Ma-Weaver. Mr. Ma-Weaver, Funicular Funds, LP, and Cable Car Capital LLC may be deemed to be members of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.
Grant to the Reporting Person of a stock option under the 2020 Equity Incentive Plan, vesting in 12 equal monthly installments beginning as of January 30, 2024, subject to the Reporting Person continuing to provide Continuous Service (as defined in the 2020 Equity Incentive Plan) through such date. If the Reporting Person's service as a director of the Issuer terminates in connection with or at any time following a change in control (for whatever reason), then any unexpired options that remain unvested shall become fully vested.
Jacob Ma-Weaver
2024-01-31